ZA974334B - Fluorinated Vitamin D3 analogs. - Google Patents

Fluorinated Vitamin D3 analogs.

Info

Publication number
ZA974334B
ZA974334B ZA9704334A ZA974334A ZA974334B ZA 974334 B ZA974334 B ZA 974334B ZA 9704334 A ZA9704334 A ZA 9704334A ZA 974334 A ZA974334 A ZA 974334A ZA 974334 B ZA974334 B ZA 974334B
Authority
ZA
South Africa
Prior art keywords
analogs
fluorinated vitamin
fluorinated
vitamin
Prior art date
Application number
ZA9704334A
Other languages
English (en)
Inventor
Bernard Michael Hennessy
Milan Radoje Uskokovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZA974334B publication Critical patent/ZA974334B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA9704334A 1996-05-23 1997-05-19 Fluorinated Vitamin D3 analogs. ZA974334B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1818796P 1996-05-23 1996-05-23

Publications (1)

Publication Number Publication Date
ZA974334B true ZA974334B (en) 1997-11-24

Family

ID=21786696

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9704334A ZA974334B (en) 1996-05-23 1997-05-19 Fluorinated Vitamin D3 analogs.

Country Status (30)

Country Link
US (1) US5888994A (ja)
EP (1) EP0808831B1 (ja)
JP (1) JP2858571B2 (ja)
KR (1) KR100237523B1 (ja)
CN (1) CN1081184C (ja)
AR (1) AR007240A1 (ja)
AT (1) ATE195514T1 (ja)
AU (1) AU720098B2 (ja)
BR (1) BR9703373A (ja)
CA (1) CA2204478C (ja)
CO (1) CO4840512A1 (ja)
CZ (1) CZ157997A3 (ja)
DE (1) DE69702812T2 (ja)
DK (1) DK0808831T3 (ja)
ES (1) ES2150719T3 (ja)
GR (1) GR3034832T3 (ja)
HR (1) HRP970274A2 (ja)
HU (1) HUP9700927A3 (ja)
IL (1) IL120842A0 (ja)
MA (1) MA24345A1 (ja)
NO (1) NO971934L (ja)
NZ (1) NZ314838A (ja)
PL (1) PL320131A1 (ja)
PT (1) PT808831E (ja)
SG (1) SG50831A1 (ja)
TR (1) TR199700418A2 (ja)
TW (1) TW374762B (ja)
UY (1) UY24563A1 (ja)
YU (1) YU19997A (ja)
ZA (1) ZA974334B (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO971934L (no) * 1996-05-23 1997-11-24 Hoffmann La Roche Flourinerte vitamin D3 -analoger
JP2002505668A (ja) * 1997-05-16 2002-02-19 ウィメン アンド インファンツ ホスピタル 環状エーテルビタミンＤ３化合物、１α（ＯＨ）３−エピ−ビタミンＤ３化合物及びそれらの使用法
WO1998051664A1 (en) * 1997-05-16 1998-11-19 Women & Infants Hospital 3-epi vitamin d2 compounds and uses thereof
DE69814109T2 (de) * 1997-09-08 2004-02-26 F. Hoffmann-La Roche Ag 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analoga
WO2000051554A2 (en) * 1999-03-05 2000-09-08 Johns Hopkins University Regulating skin appearance and composition with a fluorinated vitamin d3 analog compound
US7148211B2 (en) * 2002-09-18 2006-12-12 Genzyme Corporation Formulation for lipophilic agents
AU2005303773A1 (en) 2004-11-12 2006-05-18 Bioxell Spa Combined use of vitamin D derivatives and anti-proliferative agents for treating bladder cancer
SI3095447T1 (sl) 2006-02-03 2022-02-28 Opko Renal, Llc Zdravljenje pomanjkanja vitamina D s 25-hidroksivitaminom D2 in 25-hidroksivitaminom D3
JP5563296B2 (ja) 2006-06-21 2014-07-30 プロヴェンティヴ セラピュティックス リミテッド ライアビリティ カンパニー 二次性副甲状腺機能亢進症の治療及び予防方法
CA2943032C (en) 2007-04-25 2019-05-07 Cytochroma Inc. Oral controlled release compositions comprising vitamin d compound and waxy carrier
CN101668532B (zh) 2007-04-25 2014-08-20 赛特克罗公司 治疗维生素d不足和缺乏、继发性甲状旁腺功能亢进症和维生素d-响应疾病的组合物及其相应的制药用途
WO2011123476A1 (en) 2010-03-29 2011-10-06 Cytochroma Inc. Methods and compositions for reducing parathyroid levels
US8754067B2 (en) 2010-11-12 2014-06-17 Wisconsin Alumni Research Foundation 22-haloacetoxy-homopregnacalciferol analogs and their uses
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
PE20170392A1 (es) 2014-08-07 2017-04-07 Opko Ireland Global Holdings Ltd Terapia adjuntiva con 25-hidroxi vitamina d
CR20180510A (es) 2016-03-28 2019-05-15 Opko Ireland Global Holdings Ltd Método de tratamiento con vitamina d

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5039671A (en) * 1984-12-19 1991-08-13 Hoffmann-La Roche Inc. Trifluorinated-1α,25S-dihydroxy vitamin D3 compounds
US5145846A (en) * 1988-01-20 1992-09-08 Hoffmann-La Roche Inc. Vitamin D3 analogs
US4804502A (en) * 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
GB9007236D0 (en) * 1990-03-30 1990-05-30 Leo Pharm Prod Ltd Chemical compounds
GB9017890D0 (en) * 1990-08-15 1990-09-26 Leo Pharm Prod Ltd Chemical compounds i
US5206230A (en) * 1991-06-05 1993-04-27 Daikin Industries, Ltd. Fluorine-containing vitamin D3 analogues and pharmaceutical composition containing the same
US5210237A (en) * 1991-08-27 1993-05-11 Daikin Industries, Ltd. Vitamin d3 analogues
US5200536A (en) * 1992-02-10 1993-04-06 Daikin Industries Ltd. Fluorine-containing vitamin D3 analogues
GB9206648D0 (en) * 1992-03-26 1992-05-06 Leo Pharm Prod Ltd Chemical compounds
DE69304279T2 (de) * 1992-05-20 1997-02-20 Hoffmann La Roche Fluorierte Analoge Vitamins D3
CA2096105A1 (en) * 1992-10-07 1994-04-08 Enrico Giuseppe Baggiolini (Deceased) Vitamin d3 fluorinated analogs
TW267161B (ja) * 1992-11-20 1996-01-01 Hoffmann La Roche
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
US5384314B1 (en) * 1994-03-11 1997-08-05 Hoffmann La Roche 1alpha-fluoro-25-hydroxy-16-ene-23-yne-cholecalciferol
NO971934L (no) * 1996-05-23 1997-11-24 Hoffmann La Roche Flourinerte vitamin D3 -analoger

Also Published As

Publication number Publication date
MA24345A1 (fr) 1998-07-01
JP2858571B2 (ja) 1999-02-17
ES2150719T3 (es) 2000-12-01
CO4840512A1 (es) 1999-09-27
MX9703776A (es) 1998-06-30
TR199700418A3 (tr) 1997-12-21
DK0808831T3 (da) 2001-01-02
YU19997A (sh) 1999-07-28
TW374762B (en) 1999-11-21
NO971934L (no) 1997-11-24
NO971934D0 (no) 1997-04-25
GR3034832T3 (en) 2001-02-28
EP0808831A3 (en) 1999-02-03
CA2204478A1 (en) 1997-11-23
HRP970274A2 (en) 1998-04-30
IL120842A0 (en) 1997-09-30
SG50831A1 (en) 1998-07-20
CN1081184C (zh) 2002-03-20
CZ157997A3 (en) 1997-12-17
CA2204478C (en) 2006-11-21
DE69702812T2 (de) 2001-01-25
AU720098B2 (en) 2000-05-25
AU2357297A (en) 1997-11-27
EP0808831B1 (en) 2000-08-16
HU9700927D0 (en) 1997-07-28
KR100237523B1 (ko) 2000-01-15
KR970074763A (ko) 1997-12-10
AR007240A1 (es) 1999-10-27
DE69702812D1 (de) 2000-09-21
PL320131A1 (en) 1997-11-24
ATE195514T1 (de) 2000-09-15
BR9703373A (pt) 1998-09-15
CN1169425A (zh) 1998-01-07
HUP9700927A3 (en) 1999-07-28
NZ314838A (en) 1998-01-26
JPH1045712A (ja) 1998-02-17
HUP9700927A2 (hu) 1998-01-28
EP0808831A2 (en) 1997-11-26
PT808831E (pt) 2000-12-29
UY24563A1 (es) 2000-12-29
TR199700418A2 (xx) 1997-12-21
US5888994A (en) 1999-03-30

Similar Documents

Publication Publication Date Title
ZA974336B (en) Vitamin D3 analogs.
ZA974334B (en) Fluorinated Vitamin D3 analogs.
ZA976242B (en) Illudin analogs useful as antitumor agents.
EP0996458A4 (en) SANDRAMYCIN ANALOG
HK1047578A1 (en) Vitamin d3 analogs.
ZA9711567B (en) Compounds.
ZA97944B (en) N: 1 Transcoder.
ZA975861B (en) Bromotiacumicin compounds.
SG70010A1 (en) Fluorinated vitamin d3 analogs
ZA972944B (en) Novel retinoids.
ZA974332B (en) Fluorinated vitamin D3 analogs.
ZA974056B (en) New thiazolopyridines.
ZA979404B (en) Aspirinate compounds.
GB9601685D0 (en) Fluorinated compounds
SG24096A1 (en) Fluorinated vitamin D3 derivative
ZA9610663B (en) Wetsuit.
ZA978284B (en) Staircases.
GR2001944Y (en) Kinesthisiometer -goniometer feet.
ZA978645B (en) Lighting equipment.
ZA986155B (en) (+)-norcisapride.